SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-009287
Filing Date
2023-03-28
Accepted
2023-03-28 16:32:07
Documents
15
Period of Report
2023-03-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 49659
2 ex99-1.htm EX-99.1 14357
3 ex99-1_001.jpg GRAPHIC 18605
  Complete submission text file 0001493152-23-009287.txt   323325

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hrow-20230327.xsd EX-101.SCH 4149
5 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hrow-20230327_def.xml EX-101.DEF 27404
6 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hrow-20230327_lab.xml EX-101.LAB 37859
7 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hrow-20230327_pre.xml EX-101.PRE 26021
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6522
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 23770029
SIC: 2834 Pharmaceutical Preparations